Plus   Neg

Regeneron Pharmaceuticals Q3 adjusted earnings Beat Estimates

Regeneron Pharmaceuticals (REGN) released a profit for its third quarter that advanced from last year.

The company's profit came in at $669.6 million, or $5.86 per share. This compares with $594.7 million, or $5.17 per share, in last year's third quarter.

Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $761.8 million or $6.67 per share for the period.

Analysts had expected the company to earn $6.36 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 23.5% to $2.05 billion from $1.66 billion last year.

Regeneron Pharmaceuticals earnings at a glance:

-Earnings (Q3): $761.8 Mln. vs. $675.4 Mln. last year.
-EPS (Q3): $6.67 vs. $5.87 last year.
-Analysts Estimate: $6.36
-Revenue (Q3): $2.05 Bln vs. $1.66 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT